Quantcast

Three men sue Janssen Research and Development, others over alleged risks of Xarelto

LOUISIANA RECORD

Sunday, December 22, 2024

Three men sue Janssen Research and Development, others over alleged risks of Xarelto

Shutterstock 190751591

NEW ORLEANS – Three men are suing a major drug corporation alleging that the company was negligent in not advising patients of the risks associated with taking Xarelto.

John Dobbs of Tennessee, Joseph Larson of Illinois and John Ostrander of West Virginia filed a complaint on June 17 in the U.S. District Court for the Eastern District of Louisiana against Janssen Research and Development LLC, et al. alleging negligence, strict liability, manufacturing defect, design defect, failure to warn and other counts.

According to the complaint, the men were prescribed Xarelto to reduce the risk of stroke, systemic embolism or other health issues. At no time during their treatment with the drugs were the men made fully aware of the risks associated with taking the medication, the complaint states.. However, in 2013 the men all began to experience painful and dangerous side effects that were allegedly directly related to the ingestion of the medication. The men are suing the corporation alleging that it was negligent to fail to warn them of the risks, claiming that the injuries suffered have negatively impacted their lives.

They are seeking compensation for all damages received, financial and physical. They are represented by Brian J. Perkins of Meyers and Flowers LLC in St. Charles. The case has been assigned to Judge Eldon Fallon.

U.S. District Court for the Eastern District of Louisiana Case number 2:15-cv-02198

More News